Reversion of antibiotic resistance inMycobacterium tuberculosisby spiroisoxazoline SMARt-420
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Reversion of antibiotic resistance inMycobacterium tuberculosisby spiroisoxazoline SMARt-420
Authors
Keywords
-
Journal
SCIENCE
Volume 355, Issue 6330, Pages 1206-1211
Publisher
American Association for the Advancement of Science (AAAS)
Online
2017-03-17
DOI
10.1126/science.aag1006
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Acquired Resistance to Bedaquiline and Delamanid in Therapy for Tuberculosis
- (2015) Guido V. Bloemberg et al. NEW ENGLAND JOURNAL OF MEDICINE
- More than just bugs in spit
- (2015) C. Barry SCIENCE
- The Future of Antibiotics and Resistance: A Tribute to a Career of Leadership by John Bartlett
- (2014) B. Spellberg et al. CLINICAL INFECTIOUS DISEASES
- Evolution and transmission of drug-resistant tuberculosis in a Russian population
- (2014) Nicola Casali et al. NATURE GENETICS
- Consequences of genomic diversity in Mycobacterium tuberculosis
- (2014) Mireia Coscolla et al. SEMINARS IN IMMUNOLOGY
- para-Aminosalicylic Acid Is a Prodrug Targeting Dihydrofolate Reductase inMycobacterium tuberculosis
- (2013) Jun Zheng et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The TetR Family of Regulators
- (2013) L. Cuthbertson et al. MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS
- Out-of-Africa migration and Neolithic coexpansion of Mycobacterium tuberculosis with modern humans
- (2013) Iñaki Comas et al. NATURE GENETICS
- Discovery of Novel N-Phenylphenoxyacetamide Derivatives as EthR Inhibitors and Ethionamide Boosters by Combining High-Throughput Screening and Synthesis
- (2012) Marion Flipo et al. JOURNAL OF MEDICINAL CHEMISTRY
- Unexpected high levels of multidrug-resistant tuberculosis present new challenges for tuberculosis control
- (2012) Sven Hoffner LANCET
- Multidrug Resistant Pulmonary Tuberculosis Treatment Regimens and Patient Outcomes: An Individual Patient Data Meta-analysis of 9,153 Patients
- (2012) Shama D. Ahuja et al. PLOS MEDICINE
- Overview of theCCP4 suite and current developments
- (2011) Martyn D. Winn et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- Ethionamide Boosters: Synthesis, Biological Activity, and Structure−Activity Relationships of a Series of 1,2,4-Oxadiazole EthR Inhibitors
- (2011) Marion Flipo et al. JOURNAL OF MEDICINAL CHEMISTRY
- Ethionamide Boosters. 2. Combining Bioisosteric Replacement and Structure-Based Drug Design To Solve Pharmacokinetic Issues in a Series of Potent 1,2,4-Oxadiazole EthR Inhibitors
- (2011) Marion Flipo et al. JOURNAL OF MEDICINAL CHEMISTRY
- Exploring Drug Target Flexibility Usingin SituClick Chemistry: Application to a Mycobacterial Transcriptional Regulator
- (2010) Nicolas Willand et al. ACS Chemical Biology
- XDS
- (2010) Wolfgang Kabsch ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- Features and development ofCoot
- (2010) P. Emsley et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- Molecular replacement withMOLREP
- (2009) Alexei Vagin et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- Synthetic EthR inhibitors boost antituberculous activity of ethionamide
- (2009) Nicolas Willand et al. NATURE MEDICINE
- A synthetic mammalian gene circuit reveals antituberculosis compounds
- (2008) W. Weber et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started